AG
RIGL icon

Artal Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Artal Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,110
Closed -$851K – 145
2021
Q4 		$851K Hold
32,110
– – 0.02% 141
2021
Q3 		$1.17M Hold
32,110
– – 0.03% 141
2021
Q2 		$1.39M Hold
32,110
– – 0.03% 140
2021
Q1 		$1.1M Hold
32,110
– – 0.02% 142
2020
Q4 		$1.12M Hold
32,110
– – 0.02% 127
2020
Q3 		$771K Sell
32,110
-1,690
-5% -$41.5K 0.02% 131
2020
Q2 		$619K Sell
33,800
-1,200
-3% -$21.6K 0.02% 132
2020
Q1 		$546K Buy
+35,000
New +$745K 0.02% 102

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group's RIGL Position: Q1 2022 in Review

Artal Group sold out of Rigel Pharmaceuticals (RIGL) in Q1 2022, closing a stake of 32,110 shares — an estimated $851K sold.

Artal Group first reported a position in RIGL in Q1 2020 and held it in 8 quarters. The position peaked at $1.39M in Q2 2021. 163 funds tracked by Wall St. Rank hold RIGL as of Q1 2022.

  • Artal Group reported no remaining Rigel Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Artal Group sold 32,110 Rigel Pharmaceuticals shares in Q1 2022, an estimated $851K.
  • Artal Group first reported a position in Rigel Pharmaceuticals in Q1 2020 and held it in 8 quarters.
  • Artal Group's Rigel Pharmaceuticals position peaked at $1.39M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2022.

Based on Artal Group's 13F filing for Q1 2022, filed 12 May 2022.